Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Net Issuance of Debt
Yield10 Bioscience Inc
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Net Issuance of Debt
$967k
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
-$4.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-21%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
-$270m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$2.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
-$43.1m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
6%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yield10 Bioscience Inc's Net Issuance of Debt?
Net Issuance of Debt
967k
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Net Issuance of Debt amounts to 967k USD.
What is Yield10 Bioscience Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
43%
The average annual Net Issuance of Debt growth rates for Yield10 Bioscience Inc have been 43% over the past three years .